Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data

Background: Methotrexate is the preferred initial disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA). However, clinically useful tools for individualized prediction of response to methotrexate treatment in patients with RA are lacking. We aimed to identify clinical predictors...

Full description

Bibliographic Details
Main Authors: Athreya, A. (Author), Atkinson, E.J (Author), Crowson, C.S (Author), Davis, J.M., III (Author), Duong, S.Q (Author), Matteson, E.L (Author), Myasoedova, E. (Author), Wang, L. (Author), Warrington, K.J (Author), Weinshilboum, R. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Machine learning
Methotrexate
Rheumatoid arthritis
Treatment
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items